Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379678 · ClinicalTrials.gov registry record
Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 28
- Enrollment target
NCT00379678: Completed study, sponsored by National Jewish Health.
NCT00379678 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00379678 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
THe study seeks to determine if pimecrolimus has a positive effect on increasing antimicrobial peptide expression and reducing vaccinia virus growth in the skin explants from patients with atopic dermatitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-03 |
What the finished NCT00379678 record still lists
NCT00379678 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 28 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00379678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00379678 about?
NCT00379678 is a clinical study titled "Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis". THe study seeks to determine if pimecrolimus has a positive effect on increasing antimicrobial peptide expression and reducing vaccinia virus growth in the skin explants from patients with atopic dermatitis.
What is the current status of trial NCT00379678?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-09. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00379678?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia